At a glance
- Originator Nonindustrial source
- Class Antineoplastics
- Mechanism of Action Ras protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Precursor cell lymphoblastic leukaemia-lymphoma
Most Recent Events
- 17 Aug 2001 No-Development-Reported for Acute lymphoblastic leukaemia in USA (Unknown route)
- 13 Jan 1999 Preclinical development for Acute lymphoblastic leukaemia in USA (Unknown route)